Innova Captab
DMAT
PUBLIC LIMITED
Price Chart
1W
1M
1Y
MAX
High
₹448
Low
₹448
Return
-
Buy Sell Innova Captab
As of August 08, 2026, Innova Captab, Listed Shares are trading at ₹963.00 per share.
ISIN
INE0DUT01020
An International Securities Identification Number (ISIN) is a code that uniquely identifies a specific securities issue. The numbers are allocated by a country's respective national numbering agency (NNA).
Face Value
10
Value of a security, as stated by its issuer. It has no relation with market price of the stock.
Total Shares
4,80,00,000
Total shares or total number of shares outstanding represents the amount of stock on the open market, including shares held by institutional investors and restricted shares held by insiders and company officers.
Market Cap
4,622.4 Cr
Market capitalization is the aggregate valuation of the company based on its current share price and the total number of outstanding shares.
Sector
Health Care
A sector is an area in which businesses share the same or a related product or service. It can also be known as an industry or market that shares common operating characteristics
Sub-sector
Pharmaceuticals
Subsectors are the divisions of a sector. They are areas that vary from the rest of the sector substantially enough to justify creating a plan just for the subsector.
Category
Listed
Category is defined as a class or division of things regarded as having particular shared characteristics.
About Innova Captab
Company Overview
- Innova Captab is an integrated pharmaceutical company in India with a presence across the pharmaceuticals value chain including research and development, manufacturing, drug distribution, marketing, and exports. The business includes a contract development and manufacturing organization (“CDMO”) business providing manufacturing services to Indian pharmaceutical companies, a domestic branded generics business, and an international branded generics business.
- Since its inception in 2006 with a small base, the company has grown from strength to strength, and for the last more than 15 years, Innova Captab has been catering to top Indian pharmaceutical companies including 10 of the top 10, and 14 of the top 15.
- The CDMO services and products include commercial large-scale manufacturing of generic products. The comprehensive CDMO formulation capabilities allow the company to offer its customers multiple dosage forms, including oral solids, oral liquids, dry syrups, and injectables, as well as more complex delivery forms such as modified and sustained release forms and tablets in capsules.
- Some of our key customers include Cipla Limited, Glenmark Pharmaceuticals, Wockhardt Limited, Corona Remedies, Emcure Pharmaceuticals, Lupin Limited, Intas Pharmaceuticals, Leeford Healthcare, Medley Pharmaceuticals, Cachet Pharmaceuticals, Eris Healthcare, Indoco Remedies, J. B. Chemicals and Pharmaceuticals, Oaknet Healthcare, Zuventus Healthcare, Ajanta Pharma, Mankind Pharma and Smart Laboratories.
- Innova Captab Limited is a Public incorporated on 03 January 2005, with its registered office at 606, Ratan Galaxie-6th Floor, J.N. Road, Plot No. 1, Mulund (W), Mumbai Mumbai City MH 400080 IN.
Want to See a Detailed Investment Analysis?
Explore in-depth financial analysis, performance metrics, and key disclosures.
Innova Captab
₹ 963
